These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 20861477

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis.
    Keino H, Watanabe T, Sato Y, Niikura M, Wada Y, Okada AA.
    Arthritis Res Ther; 2008; 10(5):R122. PubMed ID: 18847496
    [Abstract] [Full Text] [Related]

  • 5. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H, Ohguro N, Fujimoto M, Hohki S, Terabe F, Serada S, Nomura S, Nishida K, Kishimoto T, Naka T.
    Invest Ophthalmol Vis Sci; 2011 May 17; 52(6):3264-71. PubMed ID: 21330657
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Retinoic acid receptor stimulation ameliorates experimental autoimmune optic neuritis.
    Keino H, Watanabe T, Sato Y, Shudo K, Kitaoka Y, Harada T, Okada AA.
    Clin Exp Ophthalmol; 2015 Aug 17; 43(6):558-67. PubMed ID: 24612001
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H, Strassmann G, Chan CC, Rizzo LV, Silver PB, Wiggert B, Caspi RR.
    Invest Ophthalmol Vis Sci; 1999 Apr 17; 40(5):942-50. PubMed ID: 10102291
    [Abstract] [Full Text] [Related]

  • 15. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H, Sakai T, Tsuneoka H, Imanishi K, Saito S.
    Exp Eye Res; 2009 Oct 17; 89(4):486-93. PubMed ID: 19523946
    [Abstract] [Full Text] [Related]

  • 16. Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis.
    Takeuchi M, Yokoi H, Tsukahara R, Sakai J, Usui M.
    Jpn J Ophthalmol; 2001 Oct 17; 45(5):463-9. PubMed ID: 11583666
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
    Vistica BP, Shi G, Nugent L, Tan C, Altman A, Gery I.
    Mol Vis; 2012 Oct 17; 18():1858-64. PubMed ID: 22815639
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.